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Background: Myelin is critical for efficient axonal con-
duction in the vertebrate nervous system. Neuregulin
(Nrg) ligands and their ErbB receptors are required for
the development of Schwann cells, the glial cells that
form myelin in the peripheral nervous system. Previous
studies have not determined whether Nrg-ErbB signal-
ing is essential in vivo for Schwann cell fate specifica-
tion, proliferation, survival, migration, or the onset of
myelination.
Results: In genetic screens for mutants with disrup-
tions in myelinated nerves, we identified mutations in
erbb3 and erbb2, which together encode a heteromeric
tyrosine kinase receptor for Neuregulin ligands. Pheno-
typic analysis shows that both genes are essential for
development of Schwann cells. BrdU-incorporation
studies and time-lapse analysis reveal that Schwann
cell proliferation and migration, but not survival, are dis-
rupted in erbb3 mutants. We show that Schwann cells
can migrate in the absence of DNA replication. This un-
coupling of proliferation and migration indicates that
erbb gene function is required independently for these
two processes. Pharmacological inhibition of ErbB sig-
naling at different stages reveals a continuing require-
ment for ErbB function during migration and also pro-
vides evidence that ErbB signaling is required after
migration for proliferation and the terminal differentia-
tion of myelinating Schwann cells.
Conclusions: These results provide in vivo evidence
that Neuregulin-ErbB signaling is essential for directed
Schwann cell migration and demonstrate that this path-
way is also required for the onset of myelination in
postmigratory Schwann cells.
Introduction
Myelin is a multilayered sheath of specialized mem-
brane that insulates and protects axons in the verte-
brate nervous system, allowing fast processing speeds
and efficient transmission of action potentials over long
distances [1]. In the peripheral nervous system, spe-
cialized glial cells called Schwann cells form myelin by*Correspondence: talbot@cmgm.stanford.edu
1These authors contributed equally to this work.
2Present address: Max-Planck-Institut fu¨r Immunobiologie, Stue-
beweg 51, D-79108 Freiburg, Germany.wrapping their membranes around the axon. Schwann
cells arise from the neural crest, and previous work in
mammals has defined the developmental progression
leading from neural crest to mature myelinating Schwann
cells [2]. In mouse, Schwann cell precursors proliferate
as they migrate along growing axons [3]. Axonal sig-
nals, whose identities remain undefined, ensure sur-
vival of Schwann cell precursors and trigger the onset
of myelination [2, 4]. Schwann cells that become com-
mitted to myelination express krox20 and ensheath just
one axonal segment (an “internode”) bordered on either
side by a unmyelinated node of Ranvier [1, 5]. It is not
well understood how glial proliferation, migration, and
survival are coordinated to achieve this precise 1:1 rela-
tionship between Schwann cells and the axonal seg-
ments that they myelinate.
Investigation of Schwann cell development in mam-
mals has shown that the transcription factors Sox10,
Oct6, Brn2, and Krox20 are key regulators of different
steps in the developmental progression of peripheral
myelination [5–8]. Signals in the EGF-related Neuregulin
(Nrg) family have been implicated at numerous steps in
the development of the Schwann cell lineage including
fate specification [9], proliferation [10], survival [11], mi-
gration [12], regulating the extent of myelination [13, 14]
and triggering demyelination [15, 16]. It is not known
how Nrg signals and their ErbB receptors might regu-
late all of these functions, some of which are apparently
contradictory, but part of the answer may be that some
of the >15 different Nrg ligands and different ErbB re-
ceptor complexes have different activities [17, 18]. In
addition, it is not clear which of these putative ErbB
functions are direct and which may be consequences
of earlier action. The disruption of glial migration in
ErbB mutants, for example, may reflect a direct func-
tion in migration or an earlier function in fate specifica-
tion or proliferation, which could in turn be required
for migration.
To learn more about the genes that control glial de-
velopment and myelination, we have conducted ge-
netic screens for mutants with disruptions in mye-
linated nerves. We report that mutations in erbb3 and
erbb2 disrupt Schwann cell development, causing a
lack of myelin in peripheral nerves. By analyzing the
mutants and embryos treated with a chemical inhibitor
of ErbB signaling, we show that ErbB signaling directly
regulates multiple steps in Schwann cell development,
including proliferation, migration, and the onset of my-
elination.
Results
Molecular Analysis of Mutations in erbb3
To discover mutations in genes with essential functions
in myelination, we conducted a screen for mutants with
disrupted expression of myelin basic protein (mbp)
mRNA (H.M.P., B.D., and W.S.T., unpublished data), a
marker robustly expressed in myelinating glia in the
CNS and PNS (Figure 1) [19]. As described below, two
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514Figure 1. Molecular Analysis of Mutations in
erbb3
(A) Genetic map of a portion of LG23, show-
ing positions of erbb3, the st48 and st14 mu-
tations, and some other markers.
(B) Schematic representation of the zebra-
fish ErbB3 protein. The positions of protein
domains and lesions in the mutant alleles are
indicated; the Asn at position 835 is a defin-
ing characteristic of ErbB3 proteins.
(C and D) Expression of mbp in wild-type
and erbb3st48/st14 transheterozygote at 5 dpf.
Arrowheads point to cells expressing mbp
along two branches of the ALLn, and the ar-
row points to mbp expression along the
PLLn. In the transheterozygote, mbp expres-
sion is reduced in the ALLn and PLLn.
(E and F) Expression of mbp at 5 dpf in ani-
mals injected with erbb3 MO (F) or control
MO (E). Disruption of erbb3 function reduced
mbp expression in the ALLn and PLLn.
(G–K) Expression of erbb3 mRNA in wild-
type zebrafish embryos. (G) Dorsal view of
head region (anterior to the top) at 12 hpf
shows erbb3 expression in premigratory
neural crest. (H) Lateral view at 19 hpf shows
erbb3 expression in both premigratory and migrating neural crest. At 27 hpf (I–K), dorsal (I) and lateral (J) views show erbb3 expression in
the region of cranial ganglia and along the paths of spinal nerves. (K) Higher magnification view of PLLg, showing erbb3 expression in cells
along the path of the PLLn (arrow).mutations isolated in this screen, st14 and st48, have o
mrelated but distinct phenotypes in PNS myelination. We
mapped both mutations to the same region of linkage n
(group (LG) 23, near the marker Z6142 and the gene
wnt1 (Figure 1A). Despite the differences in mutant phe- m
Mnotype (see below), mapping and complementation
data (Figures 1C and 1D) indicated that st14 and st48 i
are allelic mutations.
Comparative synteny analysis suggested a zebrafish M
Thomolog of the neuregulin receptor erbb3 as a candi-
date for the gene disrupted by st14 and st48—no ze- a
mbrafish erbb3 gene had been described, but the erbb3
gene is located near wnt1 in the human and pufferfish W
pgenomes. We identified a zebrafish erbb3 homolog in
the Sanger Institute genomic sequence database and e
(mapped it to LG23 near wnt1—the same location as
the st14 and st48 mutations (Figure 1A). m
sThe predicted zebrafish ErbB3 protein is 54% iden-
tical to the human ErbB3 protein and has characteristic b
pErbB3 sequence features, including a kinase homology
domain that contains an asparagine residue in a posi- w
ition normally occupied by aspartic acid in kinases
(Figure 1B). As in mouse, the zebrafish erbb3 gene is p
(expressed in premigratory neural crest (Figure 1G), mi-
grating neural crest (Figure 1H), and in putative glia as- c
psociated with cranial ganglia and peripheral nerves
(Figures 1I–1K). j
eSequence analysis of erbb3 in the st48 mutant iden-
tified a premature stop codon that truncates the pre- (
mdicted protein in the extracellular domain (Figure 1B).
All st48 mutants analyzed were homozygous for this 2
lesion (n = 82). Sequence analysis of st14mutants iden-
tified a G to A mutation that changed a highly con- m
tserved Cys to a Tyr in the extracellular domain (Figure
1B). All st14 mutants analyzed were homozygous for g
gthis lesion (n = 29). Injection of an antisense morpholinoligonucleotide (MO) designed against erbb3 reduced
bp expression in the PNS (Figure 1F; 100% affected,
= 65), whereas a mismatch control MO had no effect
Figure 1E; 100% wild-type, n = 12). On the basis of
apping, identification of lesions in two alleles, and
O phenocopy experiments, we conclude that erbb3
s the gene disrupted by st14 and st48.
olecular Analysis of Mutations in erbb2
he screen for mutations disrupting mbp expression
lso yielded st50, and we found st61 in a screen for
utants with disrupted axons in the PNS (M.G.V. and
.S.T., unpublished data). Both mutants have similar
henotypes, characterized by strong reduction of mbp
xpression and defasciculation of axons in the PNS
Figures 2D, 3S, 3U, 3X, and 3Z). The st61 and st50
utations fail to complement (Figure 2D), and mapping
howed that both mutations reside on LG12, near a ze-
rafish homolog of erbb2 (Figure 2A), which encodes a
rotein that forms a heteromeric neuregulin receptor
ith ErbB3 [20]. The zebrafish gene is widely expressed
n 20–24 hpf embryos (data not shown) and encodes a
redicted protein that is 54% identical to human ErbB2
Figure 2B). Injection of antisense morpholino oligonu-
leotides showed that erbb2 is essential for mbp ex-
ression in the larval PNS: all individuals (n = 32) in-
ected with the erbb2 MO had reduced or absent mbp
xpression in the posterior lateral line nerve at 5 dpf
Figure 2F), whereas individuals injected with a mis-
atch control MO had normal mbp expression (Figure
E; n = 32).
Sequence analysis of the erbb2 gene identified a pre-
ature stop codon in st61 mutants, which truncates
he ErbB2 protein upstream of the transmembrane re-
ion (Figure 2B). All mutants sequenced were homozy-
ous for this lesion (n = 10). Analysis of erbb2 se-
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515Figure 2. Molecular Analysis of Mutations in
erbb2
(A) Genetic map of a portion of LG12, show-
ing positions of erbb2, the st61 and st50 mu-
tations, and two other markers.
(B) Schematic representation of the zebra-
fish ErbB2 protein. The positions of protein
domains and lesions in the mutant alleles are
indicated. The Asp at position 838 is typical
of ErbB proteins except ErbB3, which have
an Asn at the corresponding position.
(C and D) Expression of mbp in wild-type
and erbb2st50/st61 transheterozygote at 5 dpf.
In the transheterozygote, mbp expression is
reduced in the ALLn and PLLn (arrow).
(E and F) Expression of mbp at 5 dpf in ani-
mals injected with erbb2 MO (F) or control
MO (E). Disruption of erbb2 function reduced
mbp expression in the ALLn and PLLn
(arrow).quences in st50 mutants revealed a T>G mutation that
alters a conserved Valine (GTT) at position 58 to Glycine
(GGT) (Figure 2B). To test whether this sequence
change reduced erbb2 function, we assayed the ability
of synthetic wild-type and st50mutant mRNA to rescue
foxd3::gfp expressing Schwann cells that are missing
in erbb2 and erbb3 mutants (see Figure 4). Injection of
the wild-type erbb2 mRNA rescued foxd3::gfp expres-
sion in glia of the posterior lateral line nerve (PLLn) in
22 of 46 homozygous st50 mutants examined. The st50
mutant mRNA, however, rescued glial GFP expression
in only 1 of 66 st50 mutants examined, indicating that
the Val58Gly mutation strongly reduces erbb2 function.
On the basis of mapping, the identification of lesions in
two alleles, rescue by RNA injection, and MO pheno-
copy studies, we conclude that erbb2 is the gene dis-
rupted by the st61 and st50 mutations.
erbb3 and erbb2 Are Required for Glial Development
and Myelination in the PNS
All four erbb gene mutants are characterized by a re-
duction of mbp expression in the PNS but apparently
normal expression in the CNS (Figures 3A, 3B, 3F, 3G,
3N, 3O, 3S, 3T, 3X, and 3Y). The erbb3st48 and erbb3st14
mutations disrupt different domains of mbp expression
in the PNS and display different effects on the associ-
ated axons. For example, erbb3st14 mutants have re-
duced mbp expression in the anterior PNS (Figure 3F),
in the anterior lateral line (ALL), but normal expression
in the posterior PNS, in the posterior lateral line (PLL).
In the more severe erbb3st48 allele and both erbb2 al-
leles, mbp is reduced or absent throughout the PNS
(Figures 3N, 3S, and 3X), and the axons of the PLL
nerve are defasciculated (Figures 3P, 3U, and 3Z). Mu-
tants for both genes have normal morphology at 4 dpf,
indicating that the defects in mbp expression and axo-
nal fasciculation are specific. Analysis of marker genes
in the mutants showed that erbb3 and erbb2 are essen-
tial for early stages of glial development in the PNS:
expression of sox10 at 2 dpf and krox20 at 4 dpf, which
label migrating Schwann cells and Schwann cells com-
mitted to myelination, respectively [5, 6], was stronglyreduced in erbb2 and erbb3 mutants (Figures 3J, 3K,
3L, 3M, 3Q, 3R, 3V, 3W, and 3A#).
To examine structural components of myelin, we gen-
erated an antibody against zebrafish Mbp (Experimen-
tal Procedures). In double-label stains with an antibody
against acetylated tubulin, we found reductions in Mbp
in the erbb mutants that reflected the defects observed
for mbp mRNA (Figures 3B#–3K#). These experiments
also confirmed that the axons are present, but defasci-
culated, despite the absence of Mbp-expressing glia.
These data show that the erbb2 and erbb3 genes are
essential for the normal development of myelinating
glial cells in the PNS.
erbb3 Is Essential for Comigration of Schwann Cells
with Axons of the Posterior Lateral Line Nerve
To better understand the role of erbb3 function during
glial development and the formation of myelin in the
PNS, we made use of a stable transgenic line (foxd3::
gfp) [21] that expresses GFP in neural crest derivatives
including myelinating Schwann cells. Time-lapse con-
focal microscopy of foxd3::gfp embryos showed that a
subset of GFP-expressing neural crest cells migrate
from the dorsal neural tube and coalesce at the poste-
rior lateral line ganglion (PLLg) by 18 hpf (Figure 4A and
Movie S1 available with this article online). By about 21
hpf, some of these GFP-expressing cells migrate away
from the ganglion, along the path of the extending ax-
ons (Figure 4B and Movie S1). Previous work has
shown that these are glial cells are comigrating with
axons of the PLLn [21]. Other GFP-expressing cells re-
main in the ganglion and apparently differentiate as my-
elinating Schwann cells associated with the ganglion
(e.g., see Figure 3B).
To determine if erbb3 function is essential for
Schwann cell migration in the PLLn, we monitored
foxd3::gfp-expressing cells in erbb3st48 mutants in vivo
by time-lapse confocal microscopy. As in the wild-type,
erbb3 mutant neural crest cells migrate from the dorsal
neural tube and coalesce at the PLLg by 18 hpf (Figure
4C and Movie S2). In contrast to the wild-type, however,
GFP-expressing Schwann cells failed to migrate away
from the PLLg in erbb3 mutants (Figure 4D and Movie
Current Biology
516Figure 3. Phenotypic Analyses of erbb2 and erbb3 Mutants
(A) Lateral view of mbp expression in wild-type at 5 dpf. mbp-expressing cells are seen along the two branches of the ALLn (arrowheads)
and the PLLn (arrow).
(B) Dorsal view of mbp expression in wild-type at 5 dpf. Arrowhead indicates mbp expression in the PLLg.
(C) Lateral view of acetylated tubulin expressing axons of the PLLn (arrow) in wild-type at 5 dpf.
(D and E) Lateral views of krox20 (D) and sox10 (E) expression in glial cells along the PLLn (arrow).
(F–M) Analysis at erbb3st14 mutants with the same set of markers. In the ALLn (arrowheads), mbp, krox20, and sox10 expression are reduced,
but acetylated tubulin staining shows that axons are present.
(N–R) Analysis at erbb3st48 mutants with the same set of markers. All views are similar to those of wild-type in panels (A)–(E). Arrowhead in
(O) indicates mbp expression in the PLLg, which is sometimes observed in erbb3st48 mutants.
(S–W) Analysis at erbb2st50 mutants with the same set of markers. All views are similar to those of wild-type in panels (A)–(E).
(X–A#) Analysis at erbb2st61 mutants with the indicated markers. All views are similar to those of wild-type in panels (A)–(D).
(B#–F#) Images of double-label antibody staining preparations from the indicated genotypes showing both Mbp protein (red) and acetylated
tubulin (acTub) (green).
(G#–K#) Mbp expression alone from the same specimens shown above in panels (B#)–(F#).S2). The failure of Schwann cells to migrate from the o
fPLLg was the first phenotype that we observed in
erbb3 mutants. In erbb3 mutants, we observed no d
oSchwann cells migrating along the PLLn axons even as
late as 72 hpf, when the entire length of the nerve is S
inormally associated with glia ([21] and data not shown).
The foxd3::gfp-labeled cells that remain in the PLLg
survive through at least 72 hpf. In addition, acridine or- e
oange labeling at 28 hpf revealed no difference in the
number of apoptotic cell corpses in the PLLg of wild- T
Stype and erbb3 mutant embryos (data not shown).
Some erbb3 mutants displayed mbp expression in the B
avicinity of the PLLg (Figure 3O), suggesting that somef the GFP-expressing cells remaining in the PLLg dif-
erentiate as myelinating Schwann cells. These studies
emonstrate that erbb3 is required for cells to migrate
ut of the PLLg but is not required for migration of
chwann cell precursors to the PLLg or for glial survival
n the PLLg.
rbb3 Is Essential for Proliferation
f Schwann Cell Precursors
o determine if erbb3 is required for proliferation of
chwann cell precursors in zebrafish, we performed
rdU incorporation analyses in erbb3st48 mutants that
lso harbored the foxd3::gfp transgene. In wild-type
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517Figure 4. Disrupted Schwann Cell Migration
and Proliferation in erbb3 Mutants
(A and B) Confocal images of GFP fluores-
cence in the same foxd3::gfp transgenic
embryo at 20 hpf and 29 hpf. Cells in the
PLLg (arrowhead) and Schwann cells migrat-
ing along the PLLn (arrow in [B]) are labeled.
(C and D) Confocal images of GFP fluores-
cence in the same erbb3st48/st48; foxd3::gfp
transgenic embryo at 20 hpf and 29 hpf. La-
beled cells are seen in the PLLg (arrowhead),
but not along the path of the PLLn.
(E and F) Confocal images of GFP (green)
and BrdU (red) labeling in erbb3 mutant and
control embryos that were pulsed with BrdU
just prior to fixation at 26 hpf. These are
higher magnification views of the PLL gan-
glion and its immediate vicinity. Double-
labeled (yellow) cells are seen in the PLLg
(arrowhead) and PLLn (arrow) in the wild-
type (E). There are no double-labeled cells
visible in the erbb3 mutant (F).embryos at 26 hpf (n = 8), an average of 5.2 foxd3::gfp-
expressing PLLg cells incorporated BrdU, compared to
only 1.9 cells in erbb3 mutant siblings (n = 8) at this
stage (Figures 4E and 4F). From these studies, it was
also clear that Schwann cell precursors in the wild-type
divide as they migrate along the path of the PLLn (Fig-
ure 4E, arrow). These results demonstrate that erbb3
is necessary for normal proliferation of Schwann cell
precursors in vivo.
Schwann Cells Can Comigrate with Axons
in the Absence of Proliferation
From the foregoing analyses, it is possible that a defect
in proliferation could create a dearth of Schwann cells
that severely limits the extent of migration along the
PLLn. To determine whether proliferation is required for
Schwann cell migration, we analyzed foxd3::gfp em-
bryos in which cell division was blocked. To inhibit DNA
replication, we treated embryos with hydroxyurea and
aphidicolin beginning at 15 hpf. Analysis of the phos-
pho-histone H3 antibody, which labels cells at the
G2-M transition, showed that this treatment greatly re-
duced the number of mitotic cells between 18 and 28
hpf, which covers the period before and during which
glial cells are migrating from the PLLg (Figures 5A and
5B and data not shown). In both control and treated
embryos, foxd3::gfp-expressing cells migrated out of
the PLLg along the path of the nerve (Figures 5A and
5B), although GFP-expressing cells did not migrate
quite as far in the treated embryos as in the controls.
In both treated and control embryos, foxd3::gfp-labeled
cells were always found near the growing tips of PLLn
axons (Figures 5C and 5D), showing that Schwann cells
can migrate with axons in the absence of cell division.
It follows, therefore, that erbb3 has independent,
essential functions in proliferation and migration of
Schwann cell precursors.ErbB Signaling Is Continuously Required
during Schwann Cell Migration
In order to determine whether ErbB signaling is re-
quired transiently before migration or continuously dur-
ing migration, we sought to conditionally block ErbB
signaling with pharmacological inhibitors. Previous
studies have shown that AG1478 potently inhibits the
ErbB2/ErbB3 heterodimer, in addition to the ErbB1 re-
ceptor (EGFR) [22, 23]. Larvae incubated in 1 M
AG1478 from 10 hpf to 96 hpf had almost no Mbp ex-
pression in the PNS, whereas controls had robust Mbp
expression at this stage (Figures 6A and 6B). Mbp ex-
pression in treated larvae was very similar to erbb2 and
erbb3 mutants, consistent with previous data that
AG1478 is a specific ErbB inhibitor. In addition, treated
larvae were not morphologically distinguishable from
the controls, and we observed no nonspecific effects
of AG1478 treatment at a 4 M concentration (data not
shown). Lower doses of the drug reduced Mbp expres-
sion along the anterior lateral line nerve but left some
expression in the posterior lateral line nerve intact (Fig-
ure 6C), a phenotype similar to the weaker erbb3 allele,
erbb3st14. We also found that erbb3st48/+ heterozygous
embryos were more sensitive to AG1478 than wild-
type, providing further support that AG1478 specifically
interferes with ErbB signaling. Six of ten erbb3st48/+
heterozygous embryos treated with 0.5 M AG1478
completely lacked Mbp expression in the PLLn (Figure
6D), whereas all homozygous wild-type siblings (n = 6)
had Mbp expression in the PLLn (Figure 6C).
To determine when ErbB signaling is required for
Schwann cell migration, we examined foxd3::gfp em-
bryos treated with AG1478 at different stages. Whereas
Schwann cells occupy the entire length of the PLLn in
controls at 48 hpf (Figures 7A and 7B), Schwann cells
did not migrate as far in embryos treated with 4 M
AG1478 from 34 hpf through to 48 hpf (Figure 7C). In
embryos treated from 24 to 48 hpf, Schwann cells mi-
grated only as far as somite 5, far short of the distance
Current Biology
518Figure 5. Schwann Cell Proliferation Is Not
Required for Migration
(A and B) Foxd3::GFP-expressing control (A)
or cell-cycle-inhibited (B) embryos at 28 hpf
stained with anti-phospho-histone H3 (red)
to visualize cells in mitosis. There is a very
large reduction in the number of dividing
cells in embryos treated with hydroxyurea
and aphidicolin (B). In both images, GFP-
expressing glia (green) are seen in the PLLg
(arrowhead) and along the PLLn (arrow).
(C and D) Foxd3::GFP-expressing control (C)
or cell-cycle-inhibited (D) embryos at 28 hpf
costained with anti-acetylated tubulin (red)
to visualize axons. GFP-expressing Schwann
cells (green) are seen from the PLLg (arrow-
head) to the tip of the PLLn (arrow) in control
and cell-cycle-inhibited specimens.covered in untreated embryos (Figure 7E). Although mi- t
cgration was disrupted, death of migrating Schwann
cells was infrequent in foxd3::gfp embryos treated with
AG1478: we observed only one or two dying cells in M
ieach of three time-lapse movies (see Movie S3), and
acridine orange staining detected only a small number T
Eof foxd3::gfp expressing cell corpses in the PLLn at 32
hpf after incubation in AG1478 from 26 to 32 hpf f
b(AG1478, 1.0 cells/nerve, n = 20; control, 0.83, n = 17).
Schwann cells migrated much farther, to somite 16 on f
maverage, in embryos allowed to recover for 14 hr after
incubation in AG1478 from 24 to 34 hpf (Figure 7G). i
oImportantly, the migration of growing axons was normal
in these AG1478-treated specimens, demonstrating ferent specimens analyzed, the majority of these GFP-
Figure 6. AG1478 Specifically Blocks ErbB
Signaling and Phenocopies erbb Mutants
Confocal images of Mbp protein expression
at 4 dpf in (A) wild-type control, (B) a wild-
type animal treated with 1 M AG1478 from
10 hpf to 4 dpf, (C) a wild-type animal treated
with 0.5 M AG1478 from 10 hpf to 4 dpf,
and (D) an erbb3st48/+ heterozygote treated
with 0.5 M AG1478 from 10 hpf to 4 dpf.
The erbb3 heterozygotes are more sensitive
to low concentrations of AG1478 than their
wild-type siblings: Mbp expression remains
along the PLLn in (C) but is not detected
in (D).hat inhibition of ErbB signaling uncouples Schwann
ell-axon comigration (Figures 7D, 7F, and 7H).
isdirected Schwann Cell Movement
n the Absence of ErbB Signaling
o explore the precise nature of the requirement for
rbB signaling during Schwann cell migration, we per-
ormed time-lapse imaging of foxd3::gfp embryos incu-
ated in 4 M AG1478 beginning at 24 hpf and imaged
rom 28–48 hpf. Schwann cells stopped their directed
igration along the nerve but retained their character-
stic elongate morphology, stretched along the length
f the PLLn (Figures 7I–7K and Movie S3). In three dif-
ErbB, Glial Migration and Myelination in Zebrafish
519Figure 7. ErbB Signaling Is Required Continuously for Comigration of Schwann Cells and Axons
All panels show foxd3::gfp transgenic embryos treated with AG1478 for the indicated period (C–K) or untreated controls (A and B). (A–H)
Confocal images of GFP (green) and acetylated tubulin (red) at 48 hpf. The same cells are marked (arrowheads) in (A), (B), (C), (D), (G), and
(H); an arrow marks approximately the same position in the embryos shown in (E) and (F). Addition of AG1478 allows axons, but not Schwann
cells, to continue their directed migration. Schwann cells can resume migration after removal of AG1478 (compare [G] and [H] to [E] and [F]).
(I–K) Time-lapse imaging of foxd3::gfp-expressing Schwann cells in embryos incubated in 4 M AG1478 from 24 hpf onward. Anterior is to
the left and posterior to the right. The GFP-expressing cell highlighted with the red spot moves in the wrong direction, whereas the cell
highlighted by the blue dot does not move at all during this period (see Movie S3).expressing cells remained associated with the nerve
and moved little (Figures 7I–7K and Movie S3). Interest-
ingly, however, some Schwann cells remained motile for
a number of hours after incubation with AG1478. In
contrast to controls, we observed several cells migrat-
ing in the wrong direction along the PLLn (e.g., Figures
7I–7K and Movie S3) and other cells migrate off the
nerve (data not shown) in AG1478-treated embryos.
These time-lapse data suggest that ErbB signalingguides the direction of Schwann cell migration along
the correct path, rather than simply being required for
Schwann cell motility.
ErbB Signaling Is Required for Proliferation
and Terminal Differentiation of Postmigratory
Schwann Cells
To explore a possible role for ErbB signaling in postmi-
gratory Schwann cells, we investigated Schwann cell
Current Biology
520proliferation in foxd3::gfp embryos that were incubated g
fin 4 M AG1478 after the completion of migration at 48
hpf. In one experiment, embryos were pulsed with BrdU 3
ntwice, at 52 and 56 hpf, to maximally label dividing
cells, and we examined BrdU and GFP at 56 hpf. A i
clarge proportion of PLLn Schwann cells proliferate at
this stage; in control animals (n = 6), an average of 43.8
ffoxd3:gfp-labeled cells along the PLLn incorporated
BrdU (Figures 8A and 8C). In contrast, the PLLn of c
gAG1478-treated specimens (n = 9) contained only 29.6
cells labeled with GFP and BrdU (Figures 8B and 8C). u
aIn another experiment in which specimens were pulsed
and then examined at 76 hpf, the number of GFP- a
tlabeled Schwann cells incorporating BrdU was reduced
by about 50% in AG1478-treated animals (average M
d13.8, n = 5) compared to controls (average 26.2, n = 5)
(Figure 8C). These data show that postmigratory I
sSchwann cells undergo extensive proliferation and that
this is partly dependent on ErbB signaling. o
nIn light of the apparent requirement for Schwann cells
to adopt a 1:1 relationship with an axonal internode S
sprior to myelination, we wished to examine if postmi-Figure 8. Postmigratory Proliferation and ErbB Signaling Are Required for Schwann Cell Myelination
(A and B) Foxd3::GFP-expressing Schwann cells costained with anti-BrdU (arrowheads) after pulse labeling with BrdU at 52 hpf and 56 hpf
in (A) a control embryo and (B) an embryo incubated in 4 M AG1478 from 48 hpf until 56 hpf. Fewer double-labeled cells are observed in
AG1478-treated specimens (B).
(C) Quantification of double-labeled cells in two separate BrdU-incorporation experiments. The first and second bars illustrate the average
number of Schwann cells along the PLLn that incorporated BrdU after pulse labeling at 52 and 56 hpf in control (blue) and 4 M AG1478
incubated (red) specimens. The third and fourth bars illustrate the average number of Schwann cells along the PLLn that incorporated BrdU
after pulse labeling at 76 hpf in control (blue) and 4 M AG1478-incubated (red) specimens. The error bars show the standard deviation.
(D–G) Confocal images of Foxd3::GFP (green) and Mbp (red) in a control specimen at 4 dpf (D), a specimen incubated in the cell cycle
inhibitors HUA and AP from 48 to 72 hpf (E), a specimen incubated in 4 M AG1478 from 2 to 5 dpf (F), and a specimen incubated in 4 M
AG1478 from 3 to 5 dpf (G). GFP-labeled Schwann cells in control specimens (D) and those incubated from 3 to 5 dpf in 4M AG1478 (G)
express Mbp, whereas those incubated in cell cycle inhibitors from 48–72 hpf (E) and in 4M AG1478 from 2 to 5 dpf (F) do not.
(H and I) krox20 expression seen in cells along the PLLn in a control specimen at 4 dpf (H), but not in a specimen incubated in 4M AG1478
from 2 through 4 dpf (I).ratory proliferation was necessary for Schwann cell dif-
erentiation. After a block of cell division between 2 and
dpf, GFP-expressing Schwann cells of the PLLn did
ot express Mbp at 4 dpf (Figures 8D and 8E). This result
ndicates that proliferation of postmigratory Schwann
ells is required for myelination.
To test the prediction that ErbB signaling is required
or the onset of myelination in postmigratory Schwann
ells, we examined Mbp protein expression in foxd3::
fp larvae incubated in AG1478 from either 2 or 3 dpf
ntil 4 or 5 dpf. In control embryos, foxd3::gfp cells
long the entire length of the PLLn express Mbp protein
t 4 and 5 dpf (Figure 8A and data not shown). In con-
rast, almost no foxd3::gfp-labeled cells expressed
bp in specimens incubated in 4 M AG1478 from 2
pf to 4 dpf or 5 dpf (Figure 8F and data not shown).
nterestingly, foxd3::gfp-labeled cells expressed Mbp in
pecimens placed in 4 M AG1478 from 3 dpf to 4 dpf
r 5 dpf (Figure 8G). These data indicate that ErbB sig-
aling is required between 2 and 3 dpf for the onset of
chwann cell myelination. We also examined expres-
ion of krox20, a marker of myelinating Schwann cells
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521that is expressed prior to mbp but after Schwann cells
have committed to a myelinating fate. Schwann cells in
the PLLn expressed krox20 in all controls (n = 10; Figure
8H), but not in specimens treated with 4 M AG1478
between 2 and 4 dpf (n = 14; Figure 8I). This result
shows that ErbB signaling is required for Schwann cells
to commit to myelination.
Discussion
Using the zebrafish for a genetic analysis of myelina-
tion, we have investigated the roles of ErbB3 and ErbB2
in the peripheral nervous system. Genetic screens for
mutations that disrupt myelinated axons identified mu-
tations in erbb2 and erbb3. Our analysis indicates that
the reduction of Schwann cells in peripheral nerves is
the primary defect in erbb2 and erbb3mutants. We also
observe that axons in the affected nerves are defas-
ciculated, a phenotype previously shown to result from
the loss of PNS glia [21]. Nrg1, ErbB2, and ErbB3
mouse mutants all show reduced numbers of devel-
oping Schwann cells in peripheral nerves [24–26], but
these studies have not determined whether this lack of
Schwann cells results from disruption of fate, prolif-
eration, survival, or migration of developing Schwann
cells. Our analysis of phenotypes caused by mutation
and a chemical inhibitor demonstrates a requirement
for ErbB signaling for Schwann cell proliferation in vivo,
a continuous requirement for ErbB signaling during
Schwann cell migration, and a role in regulating postmi-
gratory proliferation, which is necessary for the onset
of myelination.
Role of ErbB Signaling in Schwann Cell
Proliferation and Migration
In zebrafish erbb3 and erbb2 mutants, analysis of the
foxd3::gfp transgene showed that Schwann cell precur-
sors migrate to and persist in the PLLg but rarely, if
ever, migrate along the path of PLLn. BrdU incorpora-
tion studies demonstrated that proliferation of Schwann
cell precursors is strongly reduced in erbb3 mutants.
Although a wealth of evidence indicates that Nrg acts
as mitogen for cultured neonatal Schwann cells (e.g.,
[10, 27]), these results are the first demonstration that
ErbB signaling is required for proliferation of premigra-
tory Schwann cell precursors in vivo. Our results con-
trast with a previous study finding no change in overall
BrdU incorporation in the dorsal root ganglion of mouse
ErbB2 mutants in which the early heart defects were
rescued with a transgene [28]. It is unclear whether this
relates to differences in the species, cell types, or gan-
glia analyzed in the two studies. Our finding that prolif-
eration of premigratory Schwann cells is reduced in
erbb3 mutants also raised the possibility that the mi-
gration defect might be a secondary consequence of
reduced Schwann cell numbers.
To directly address whether proliferation is required
for Schwann cell migration, we analyzed the PLLn of
animals treated with inhibitors of DNA replication. Al-
though PLLn axons did not progress as far as untreated
controls, Schwann cells were present near the growing
tips of the axons, just as they are in the wild-type. This
experiment provides clear evidence that proliferationand migration can be uncoupled in vivo, even though
Schwann cells normally divide during migration. More-
over, this uncoupling demonstrates that migration de-
fects in erbb3mutants do not result simply from disrup-
tion of proliferation.
The foregoing studies do not distinguish whether
erbb3 functions during Schwann cell migration or at an
earlier stage to advance cells to a state where they be-
come competent to migrate. Support for the latter
model derives from a previous study that analyzed mi-
gration in cultured ErbB2 mutant Schwann cells [28]. In
that study, ErbB2mutant Schwann cells did not migrate
as far along a sciatic nerve section as cells taken from
control embryos. Neuregulin did not enhance the mi-
gration of either control or ErbB2mutant Schwann cells
in these cultures, so the authors suggested that Nrg-
ErbB signaling might function to promote competence
to migrate rather than directly regulating migration in
Schwann cells as they move along axons [28].
We used the ErbB inhibitor AG1478 to determine
whether ErbB functions directly during migration or to
promote competence for migration at an earlier stage.
Addition of AG1478 at different times showed that mi-
grating Schwann cells could be disrupted at different
positions in their directed migration along the length of
the nerve. In these experiments, axon pathfinding was
not disrupted, demonstrating that ErbB signaling is
required to couple migrating Schwann cells with grow-
ing axons. Time-lapse imaging showed that some
Schwann cells are motile in AG1478-treated embryos
but that the movement of these cells is misdirected,
such that they may move back toward the ganglion or
even move off the PLLn. This experiment suggests that
ErbB signaling is required for directed Schwann cell
migration not simply for motility. AG1478-inhibited
Schwann cells resume directed migration upon removal
of the drug, demonstrating that Schwann cells remain
competent to respond to axonal cues even after a pro-
tracted period of disrupted migration. Together, these
experiments demonstrate a direct and continuous role
for ErbB signaling during Schwann cell migration, and
we propose that ErbB proteins are the receptors for the
axonal attractants that direct Schwann cell migration
during the development of myelinated nerves.
ErbB Signaling during Schwann Cell
Terminal Differentiation
The regulation of Schwann cell number and the forma-
tion of a one-to-one relationship with an axonal in-
ternode is associated with the onset of myelination [2].
It is, however, unclear how this cellular relationship is
achieved and how it might regulate commitment to my-
elination. The establishment of the correct numerical
relationship between axons and glia is likely to be de-
termined by balancing cell proliferation and death in
postmigratory Schwann cells. Nrg-ErbB signaling can
regulate both of these processes in cultured cells [4,
10, 11], and Nrg can prevent Schwann cell death in-
duced by transecting axons during the period of my-
elination [29]. Although these studies show that neureg-
ulin can regulate Schwann cell proliferation and survival
in certain situations, it remains unclear whether Neg
signals regulate Schwann cell number during myelina-
tion in vivo.
Current Biology
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aation of Schwann cells is regulated by ErbB signaling
oand is essential for the initiation of myelination. BrdU
b
incorporation studies showed that Schwann cells un- n
dergo increased proliferation after migration. Using the m
Zfoxd3::gfp transgene, we did not observe significant
ndeath of postmigratory Schwann cells prior to myelina-
mtion, suggesting that proliferation rather than cell death
ris regulated to achieve the correct number of Schwann
t
cells relative to axons. Inhibition of ErbB signaling in f
postmigratory cells disrupts their proliferation. We find P
Gthat either inhibiting ErbB signaling or blocking cell divi-
dsion after migration prevents the onset of Schwann cell
myelination. Inhibition of ErbB signaling one day after
the completion of migration did not cause any defect M
Tin Mbp expression, suggesting that Schwann cells
fcommit to myelination during this period. Furthermore,
bour results indicate that postmigratory ErbB signaling
Dis required for the initiation of myelination, as we do not
T
see krox20 expression in AG1478-treated specimens. w
Our results suggest that ErbB receptors receive the ax- s
donal signals that regulate Schwann cell number and
Ttrigger the onset of myelination.
eTogether with previous studies in mouse, our results
bsuggest that Nrg signals both initiate myelination and
G
regulate the thickness of myelin formed by Schwann s
cells after they commit to myelination. Analysis of Nrg- v
5ErbB signaling in mouse models shows that a condi-
Ctional knockout of ErbB2 in Schwann cells already
committed to myelination reduces the thickness of the
resulting myelin [13], and transgenic overexpression of M
MNrg caused myelin to be significantly thicker than war-
aranted by axonal diameter [14]. Our data show an addi-
ctional requirement for ErbB at earlier stages, in the pro-
Cliferative phase leading up to krox20 expression and
C
commitment to myelination. It is not known how axonal w
Nrg signals might increase Schwann cell proliferation e
2to establish the proper number of cells for myelination
and also regulate myelin thickness in differentiated




Our analysis has established multiple roles for ErbB e
csignaling in Schwann cell development and myelination
ein zebrafish. ErbB signaling is essential for proliferation
(of Schwann cell precursors in the ganglion and also for
5
these cells to begin their migration along growing ax- s
ons. ErbB signaling continues to be required for di- d
rected migration along peripheral axons. ErbB signaling m
2also regulates postmigratory Schwann cell prolifera-




The erbb3st48, erbb3st14, and erbb2st50 mutations were identified in s
a screen for ENU-induced mutations that disrupt mbp expression m
at 5 dpf (H.M.P., B.D., and W.S.T., unpublished data). The erbb2st61 w
mutation was identified in a screen for ENU-induced mutations that w
disrupt the axons of the PLLn (M.G.V. and W.S.T., unpublished
data). foxd3::gfp fish [21] were kindly provided by D. Gilmour.
B
EGenetic Mapping
Mutations were mapped by bulked segregant analysis with SSLPs i
tby standard methods [30]. Initial mapping indicated that SSLParker Z6142 was near st14 (one recombinant among 40 meioses)
nd st48 (zero recombinants among 16 meioses). Mapping with
ther markers confirmed the map assignments and indicated that
oth mutations were tightly linked to erbb3 (st14, zero recombi-
ants among 58 meioses; st48, zero recombinants among 164
eioses). The st50mutation was initially mapped to LG12, between
1473 (three recombinants/20 meioses) and Z8460 (five recombi-
ants/20 meioses). Subsequent experiments confirmed the assign-
ent to LG12 and showed that st50 is tightly linked to erbb2 (zero
ecombinants/40 meioses). Mapping experiments placed st61 in
he same region of LG12 as st50 (17 recombinants/102 meioses
rom Z10122). A polymorphism in the erbb3 gene in the Heat Shock
anel [31] was detected by PCR (primers, 5#-AGATTCATCCTTA
ACTGAATGG-3# and 5#-GCAACAACCCGTCACAGGGAA-3#) and
igestion with the restriction enzyme MseI.
olecular Analysis of erbb Genes and Mutations
o obtain full-length coding sequences of erbb2 and erbb3, we per-
ormed rapid amplification of cDNA ends on RNA from 25 hpf em-
ryos. The erbb3st48 mutation was scored in individual genomic
NA samples by digesting a PCR product (primers, 5#-GTGTCTG
TGCAGAATGGTAAA-3# and 5#-AGAAAACCCTGACTGGACCA-3#)
ith the restriction enzyme Hpy8I. The erbb3st14 mutation was
cored in individual genomic DNA samples by digesting a PCR pro-
uct (primers, 5#-TCCTGCAATCCTGCATGTGG-3# and 5#-TACCAA
CCCCCATTACCTG-3#) with the restriction enzyme BsaBI. The
rbb2st50 mutation was scored in individual genomic DNA samples
y digesting a PCR product (primers, 5#-CAGTATGTCTCGGGACC
AT-3# and 5#-GTGTAATCTCCAGGTTACCGTGA-3#) with the re-
triction enzyme Hpy8I. The erbb2st61 mutation was scored in indi-
idual genomic DNA samples by digesting a PCR product (primers,
#-TGAAGAATGCTGGTAGCTGG-3# and 5#-GGACTCAGCAAAGGA
TTAC-3#) with the restriction enzyme BsrGI.
orpholino and RNA Injection
orpholinos for erbb2 (5#-GTCCGCCTCCATCGATTATTCCTCC-3#)
nd erbb3 (5#-TGGGCTCGCAACTGGGTGGAAACAA-3#) and their
orresponding mismatch controls (erbb2 conMO, 5#-GTCCGCCAC
ATCTATTATGCCACC-3# and erbb3 conMO1, 5#-TGGACTCGCAA
AGGGCGGATACAA-3#) were obtained from Gene Tools. Embryos
ere injected at the single-cell stage with approximately 340 pg
rbB3MO, 340 pg erbB3conMO, 570 pg erbB2MO, or 830 pg erbB-
conMO.
The full-length wild-type erbb2 ORF was amplified via RT-PCR
rom 24 hpf RNA (primers, 5#-CCACCATGGAGGCGGACAGAAG
TT-3# and 5#-AGCTTTAGGTGTACTCCTTGT-3#) and inserted into
he pCRII vector (Invitrogen) to generate expression constructs.
he erbb2 ORF was resequenced and subcloned into the pCS2+
xpression vector. For generation of the erbbst50 mutant expression
onstruct, the Val58Gly mutation was introduced into the wild-type
rbb2 expression construct by site-directed mutagenesis via PCR
primers, 5#-GGCTGTCAGGTGGGTCATGGTAACCTGGAGAT-3# and
#-ATCTCCAGGTTACCATGACCCACCTGACAGCC-3#), followed by
equencing to determine that no other coding changes were intro-
uced. Both constructs were linearized with NotI, and synthetic
RNAs were synthesized with the SP6 polymerase. Approximately
00 pg of synthetic mRNA was injected into single-cell embryos
btained from erbb2st50/+; foxd3::gfp/+ intercrosses.
ime-Lapse Imaging
ime-lapse imaging was performed on a Zeiss Pascal LSM5 confo-
al microscope with either 10× or 20× objective lenses; a heated
tage kept embryos at 28.5°C during imaging. Embryos were im-
obilized in 1.5% low melting point agarose during imaging and
ere anaesthetized with 0.016% (w/v) Tricaine. Time-lapse data
as analyzed with NIH image.
rdU Labeling
mbryos were pulse labeled with 2 mg/ml BrdU in 15% DMSO on
ce for 20 min. After incubation with BrdU, embryos were returned
o embryo medium at 28.5°C for at least 15 min to recover.
ErbB, Glial Migration and Myelination in Zebrafish
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For blocking cell division, embryos were incubated in a combina-
tion of 150 M aphidicolin (Sigma) and 20 mM hydroxyurea (Sigma)
plus 4% DMSO to aid drug penetration. We found that it took 4 hr
for this drug combination to be most effective, whereupon it almost
completely blocks cell division. This is very similar to the action of
these drugs in blocking cell division in Xenopus embryos [32].
Conditional Inhibition of ErbB Signaling
We found that AG1478 (Calbiochem) faithfully reproduced erbbmu-
tant phenotypes without producing other general defects. Stock
solutions were made in DMSO, and a final concentration of 2%
DMSO was used to aid penetration when incubating embryos in
AG1478.
In Situ Hybridization and Immunohistochemistry
In situ hybridization and antibody staining were carried out follow-
ing standard protocols. The riboprobe for mbp was generated from
a cDNA clone that we isolated from an adult brain cDNA library (a
kind gift from J. Ngai) with a probe for mbp designed from the
EST database. The sequence of the mbp cDNA clone has been
deposited in GenBank (Accession number AY860977); this is the
same gene independently characterized by Brösamle and Halpern
[19]. A 1.3 kb fragment of the gene was amplified from 24 hpf RNA
by RT-PCR (primers, 5#-CACGCTACCTTGTGGTGAGG-3# and 5#-
TGCCAGTAATCTGGGTTGTCAA-3#) and cloned into the pCRII vec-
tor (Invitrogen) to generate a riboprobe for erbb3. The orientation
of insert was determined by sequencing; the construct was linear-
ized with the restriction enzyme SpeI, and an antisense probe was
transcribed with T7 RNA polymerase.
Anti-acetylated tubulin antibody (Sigma) was used at a dilution
of 1:1000. Anti-phosphohistone H3 (Upstate) and anti-BrdU (Sigma)
were used at a dilution of 1:200. A rabbit antibody against an Mbp
peptide (CSRSRSPPKRWSTIF) conjugated to KLH with MBS was
generated commercially (Sigma Genosys). Primary antibodies were
detected with appropriate secondary antibodies conjugated to
either Alexa 488, Alexa 555, or Alexa 568 (Molecular Probes) at a
1:200 dilution. Fluorescently stained embryos were analyzed with a
Zeiss Pascal LSM5 confocal microscope.
Acridine Orange
The vital dye acridine orange (Sigma) was used to visualize apo-
ptotic cell corpses in live embryos. Embryos were incubated in 5
M acridine orange for 20 min in the dark. Embryos were washed
three times in embryo medium before imaging.
Supplemental Data
Supplemental Data include three movies and are available with this
article online at http://www.current-biology.com/cgi/content/full/
15/6/513/DC1/.
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The GenBank accession numbers for the assembled cDNA se-
quences erbb3 and erbb2 are AY863052 and AY914799, respec-
tively. The GenBank accession number for the sequence of the
mbp cDNA clone is AY860977.
